Articles in headline
Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …
Guest post by BullPharma (Portugal) :
The world is changing, and more and more challenges are in front of the Pharmaceutical Industry. In our day-to-day business vocabulary some words are mandatory – globalization, crisis, cost …
You can’t imagine our surprise today when we saw that Pfizer has announced that it will license injectable and solid dosage forms from Aurobindo. We wrote about Pfizer’s new generics strategy on monday, but we …
On 15 January 2008 the European Commission launched an inquiry into competition in the pharmaceuticals sector led by Competition Commissioner Neelie Kroes.
The report finds that big pharma uses a number of strategies to block …
On the 23rd of October, Alensa will be presenting our Pharmacy Platform and HealthBlogs network at the Health 2.0 conference in San Francisco. Health 2.0 is the leading event in eHealth with all of the …
As most of you know CPhI (Frankfurt 30th Sept - 2nd Oct), arguably the most important & influential expo in the pharmaceutical calendar, is coming up fast and this year we have purposefully kept …
